|
RNF40 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.560790E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.220010E-04 |
| Normal-vs-Stage2 |
7.593400E-01 |
| Normal-vs-Stage3 |
1.287000E-01 |
| Normal-vs-Stage4 |
2.129900E-02 |
| Stage1-vs-Stage2 |
1.815610E-02 |
| Stage1-vs-Stage3 |
4.222000E-02 |
| Stage1-vs-Stage4 |
3.752000E-01 |
| Stage2-vs-Stage3 |
4.126000E-01 |
| Stage2-vs-Stage4 |
1.373570E-01 |
| Stage3-vs-Stage4 |
3.912000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.243800E-03 |
| Normal-vs-AfricanAmerican |
2.794600E-04 |
| Normal-vs-Asian |
3.448200E-02 |
| Caucasian-vs-AfricanAmerican |
2.072100E-02 |
| Caucasian-vs-Asian |
3.739800E-01 |
| AfricanAmerican-vs-Asian |
9.764600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.999500E-02 |
| Normal-vs-Female |
2.2154000000052E-06 |
| Male-vs-Female |
2.644200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.940400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.018800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.334230E-02 |
| Normal-vs-Age(81-100Yrs) |
9.541600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.985800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.098600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.394600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.747780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.267600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.591800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.67179999999156E-06 |
| Normal-vs-Grade 2 |
2.841000E-03 |
| Normal-vs-Grade 3 |
1.046220E-02 |
| Normal-vs-Grade 4 |
6.346400E-02 |
| Grade 1-vs-Grade 2 |
1.359600E-03 |
| Grade 1-vs-Grade 3 |
8.613300E-04 |
| Grade 1-vs-Grade 4 |
4.436300E-04 |
| Grade 2-vs-Grade 3 |
7.016400E-01 |
| Grade 2-vs-Grade 4 |
3.660200E-01 |
| Grade 3-vs-Grade 4 |
5.883000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.62909999999706E-05 |
| Normal-vs-ccB subtype |
3.927000E-01 |
| ccA subtype-vs-ccB subtype |
1.395300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.787550E-02 |
| Normal-vs-N1 |
1.635720E-02 |
| N0-vs-N1 |
4.145000E-01 |
|
|
